RE:RE:to consider
I cannot see bankruptcy being an option. I mean $1.6 million in debt. That is it. That is nothing for a bio company, especially one sitting on something like this. Venture capitalists should be jumping at this unless there is knowledge already that it will not advance/pass the FDAs.